Mouse Models of Fibroproliferative Lung Disease
纤维增生性肺病小鼠模型
基本信息
- 批准号:10450039
- 负责人:
- 金额:$ 42.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAllograftingAnimal ExperimentationAnimal ModelAnimalsApoptosisBiologicalBiological AssayBleomycinBronchoalveolar Lavage FluidCD44 geneCell LineCellsChronicCollagenCollectionComputersDataDatabasesDepositionDevelopmentDisease modelDoctor of PhilosophyEnsureEpithelialEpithelial CellsEquipmentFibroblastsFibrosisFunctional disorderFundingGene DeletionGoalsGrantHAS2 geneHarvestHistologicHistologyHumanHyaluronanImmuneImmune responseIn VitroInflammationInjectionsInjuryKnowledgeLungLung TransplantationLung diseasesMeasurementMedical centerMedicineMesenchymalMessenger RNAMethodsModelingMolecularMouse StrainsMusOrganoidsOutcomePathogenesisPatientsPerformancePhenotypePlayPopulation AnalysisPrimary Cell CulturesProceduresProcessProductivityProteinsProtocols documentationPublicationsPulmonary FibrosisPulmonary InflammationResearchResearch PersonnelResourcesRoleSCID MiceSamplingSpecimenStainsStandardizationStructure of parenchyma of lungStudy modelsTamoxifenTechniquesTimeTissue BanksTissue HarvestingTissuesTrainingWorkairway remodelingcostepithelial stem cellexperienceexperimental studyin vivointerstitiallung allograftlung injurymacrophagemanmatrigelmigrationmouse modelnovelprofessorprogramssuccess
项目摘要
ABSTRACT
The purpose of Core B - Mouse Models of Fibroproliferative Lung Disease and Sample Core – is to provide a
resource for the Program investigators to conduct studies in both in vivo studies with mouse models and in
vitro primary cell culture models. The Animal Core will be led by Dianhua Jiang, M.D, Ph.D., Professor of
Medicine at Cedars-Sinai Medical Center, who is currently a PI of the Animal Core for the PPG program in the
past years and has successfully supported all the projects. During the last funding period, the animal core has
successfully supported the three projects and achieved the proposed goals, and generated multiple mouse
strains required by all different projects and performed mouse modeling studies of lung fibrosis, resulting in
several high impact publications and forming the basis for renewal of this Program grant. The responsibility of
the Core includes providing training, standard operating procedures and facilitating for mouse models of
interstitial fibrosis and CLAD and developing a core unit to support these projects. Core B will unify the three
Projects by standardizing the aspects of animal experimentation and promote interactions among those
involved in the Projects. Core B will conduct treatments required to induce fibroproliferative lung disease in
mice and be responsible for outcome measurement. Fibroproliferative lung disease models will include
intratracheal bleomycin, mouse model of CLAD, and human lung fibroblasts from IPF patients to immune
compromised mice (SCID mice). Core B will isolate, fix and process mouse lung tissues and will perform
standard histology staining for lung inflammation and fibrosis measurement. Additionally, the Core will serve to
standardize histological scoring by implementing computer-automated assessment of lung hyaluronan,
collagen, airway remodeling, epithelial cell apoptosis and inflammation. Core B will isolate, maintain and
provide program investigators with primary cell lines including lung fibroblasts, macrophages and epithelial
cells from mouse models. This facility serves to standardize culture methods across the three projects. The
Core will also generate and maintain a mouse strain and results database, organize a tissue repository and
histopathologic analysis. Centralizing the animal work in the Animal Core will reduce the cost of producing
high-quality data and will facilitate interactions among the projects. Therefore, the Animal Core will play an
important role in unifying the three Projects by standardizing all aspects of animal experimentation and
promote interactions among investigators involved in the Projects to ensure the successful completion of
studies proposed in this Program Project.
抽象的
核心 B - 纤维增生性肺病小鼠模型和样本核心 - 的目的是提供
为该计划研究人员提供小鼠模型体内研究和体内研究的资源
体外原代细胞培养模型将由 Dianhua Jiang 博士、教授领导。
Cedars-Sinai 医疗中心的医学博士,目前是该地区 PPG 项目动物核心的 PI
在过去的几年里,动物核心已经成功支持了所有项目。
成功支持三个项目并实现拟定目标,并产生多只小鼠
所有不同项目所需的菌株并进行了肺纤维化的小鼠模型研究,结果
几份高影响力的出版物,并构成续订该计划拨款的基础。
核心包括提供培训、标准操作程序和促进小鼠模型的建立
间质纤维化和 CLAD 并开发一个核心单元来支持这些项目将统一这三个项目。
通过标准化动物实验方面并促进这些方面之间的互动的项目
参与该项目的 Core B 将进行诱导纤维增生性肺病所需的治疗。
小鼠并负责结果测量,其中包括纤维增殖性肺病模型。
气管内博莱霉素、CLAD小鼠模型以及IPF患者的人肺成纤维细胞进行免疫
受损小鼠(SCID 小鼠)将分离、修复和处理小鼠肺组织并执行操作。
此外,Core 将用于肺部炎症和纤维化测量的标准组织学染色。
通过对肺透明质酸进行计算机自动评估来标准化组织学评分,
Core B 将隔离、维持和炎症。
为项目研究人员提供原代细胞系,包括肺成纤维细胞、巨噬细胞和上皮细胞
该设施用于标准化三个项目的培养方法。
Core 还将生成并维护小鼠品系和结果数据库,组织组织存储库并
将动物工作集中在动物核心中将降低生产成本。
高质量的数据,并将促进项目之间的互动,因此,动物核心将发挥作用。
通过标准化动物实验和实验的各个方面,在统一这三个项目方面发挥着重要作用
促进参与项目的研究人员之间的互动,以确保项目的成功完成
本计划项目中提出的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dianhua Jiang其他文献
Dianhua Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dianhua Jiang', 18)}}的其他基金
相似国自然基金
胸腺上皮细胞在小鼠后肢同种异体复合组织移植中的免疫调节作用及相关机制研究
- 批准号:82102354
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
过表达MicroRNA-199a-3p的BMSCs来源的外泌体抑制小鼠DC功能诱导同种异体心脏移植免疫耐受的机制研究
- 批准号:82160081
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
具有靶向识别和序贯治疗功能的纳米微球对血管化同种异体复合组织移植术后免疫抑制的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
基于T细胞亚群分化与TLR2/TRAF6信号通路探讨ESAT-6抑制同种异体移植排斥的分子免疫机制
- 批准号:82071800
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
受体tolDC诱导的供体MHC-I抗原特异性Treg诱导同种异体器官移植免疫耐受
- 批准号:81901627
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Preclinical Oxygen Imager to Model Efficient Cancer Treatment
临床前氧成像仪可模拟有效的癌症治疗
- 批准号:
9974497 - 财政年份:2019
- 资助金额:
$ 42.5万 - 项目类别:
Function of microRNAs in controlling regulatory T cell biology
microRNA 在控制调节性 T 细胞生物学中的功能
- 批准号:
8403190 - 财政年份:2012
- 资助金额:
$ 42.5万 - 项目类别:
Function of microRNAs in controlling regulatory T cell biology
microRNA 在控制调节性 T 细胞生物学中的功能
- 批准号:
8441488 - 财政年份:2012
- 资助金额:
$ 42.5万 - 项目类别: